Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.

Left ventricular (LV) dysfunction c-kit-positive, lineage-negative cardiac stem cells (CSC) improving post-infarction when given to animals. We conducted an experiment phase 1 (Stem Cell Infusion in Patients with ischemic cardiomyopathy [Scipio]) from autologous CSC for the treatment of heart failure due to ischemic heart disease.In trial stage A Scipio, patients with post-infarction LV dysfunction (ejection fraction [EF] ≤ 40%) prior to coronary artery bypass grafting were consecutively enrolled in the treatment and control groups. In stage B, patients were randomly assigned to treatment or control groups in a ratio of 2: 3 by using the block scheme of computer-generated randomization. 1 million autologous CSC given by intracoronary infusion at an average of 113 days (SE 4) after surgery; untreated controls.

Although this study is an open label, echocardiographic analysis did not know the duties of the group. The primary endpoint was a short-term security of CSC and the secondary endpoint was efficacy. A per-protocol analysis were used. This study is registered with ClinicalTrials.gov, number NCT00474461.This study is still in progress. 16 patients were assigned to the treatment group and seven for the control group; no side effects were reported related CSC.

On 14 CSC-treated patients were analyzed, LVEF increased from 30 · 3% (SE 1 · 9) before CSC infusion to 38 · 5% (2 · 8) at 4 months after infusion (p = 0 · 001). In contrast, the seven control patients, as long as the appropriate time interval, LVEF did not change (30 · 1% [2 · 4] at 4 months after CABG vs 30 · 2% [2 · 5] at 8 months after CABG). Importantly, CSC healthful effects are even more pronounced in the first year in eight patients (eg, LVEF increased by 12 · 3 unit ejection fraction [2 · 1] vs baseline, p = 0 · 0007).

In seven patients treated in whom cardiac MRI can be done, infarct size decreased from 32 · 6 g (6 · 3) by 7 · 8 g (1 · 7; 24%) at 4 months (p = 0 · 004) and 9 · 8 g (3 · 5; 30%) at 1 year (p = 0 · 04) .This preliminary results in patients with very encouraging. They suggest that intracoronary infusion of autologous CSC effective in improving LV systolic function and reduced infarct size in patients with heart failure after myocardial infarction, and warrant further, larger, phase 2 studies.University of Louisville Research Foundation and the National Institutes of Health ,

D-Luciferin sodium salt

B8311-50 50 mg
EUR 293

D-Luciferin (sodium salt)

HY-12591 50mg
EUR 153

D-Luciferin, Sodium Salt

7902-100
EUR 120

D-Luciferin, Sodium Salt

7902-10G
EUR 2409

D-Luciferin, Sodium Salt

7902-10PK
EUR 2763

D-Luciferin, Sodium Salt

7902-1G
EUR 354

D-Luciferin, Sodium Salt

7902-25G Ask for price

D-Luciferin, Sodium Salt

7902-3PK
EUR 925

D-Luciferin, Sodium Salt

7902-50G Ask for price

D-Luciferin, Sodium Salt

7902-5PK
EUR 1496

D-Luciferin, sodium salt

10102 10MG
EUR 123
Description: Minimum order quantity: 1 unit of 10MG

D-Luciferin, sodium salt

10102-1 50MG
EUR 245
Description: Minimum order quantity: 1 unit of 50MG

D-Luciferin, sodium salt

10102-2 1G
EUR 714
Description: Minimum order quantity: 1 unit of 1G

D-Luciferin potassium salt

HY-12591B 50mg
EUR 153

D-Luciferin, Potassium Salt

7903-100
EUR 120

D-Luciferin, Potassium Salt

7903-10G
EUR 2409

D-Luciferin, Potassium Salt

7903-10PK
EUR 2763

D-Luciferin, Potassium Salt

7903-1G
EUR 354

D-Luciferin, Potassium Salt

7903-25G Ask for price

D-Luciferin, Potassium Salt

7903-3PK
EUR 925

D-Luciferin, Potassium Salt

7903-50G Ask for price

D-Luciferin, Potassium Salt

7903-5PK
EUR 1496

D-Luciferin, potassium salt

10101 10MG
EUR 112
Description: Minimum order quantity: 1 unit of 10MG

D-Luciferin, potassium salt

10101-1 50MG
EUR 234
Description: Minimum order quantity: 1 unit of 50MG

D-Luciferin, potassium salt

10101-2 1G
EUR 714
Description: Minimum order quantity: 1 unit of 1G

D-Luciferin, Potassium Salt

D0510-010 100mg
EUR 185

D-Luciferin, Potassium Salt

D0510-050 500mg
EUR 504

D-Luciferin, Potassium Salt

D0510-100 1g
EUR 847

D-Luciferin, sodium salt *CAS#: 103404-75-7*

12509 25 mg
EUR 115
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 41105331

D-Luciferin, sodium salt *CAS#: 103404-75-7*

12510 100 mg
EUR 132
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 41105331

D-Luciferin, sodium salt *CAS#: 103404-75-7*

12511 1 g
EUR 528
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 41105331

EZSolution? D-Luciferin, Potassium Salt

B3001-set
EUR 370

Brite-Light? D-Luciferin, Potassium Salt

B3000-10PK
EUR 2268

Brite-Light? D-Luciferin, Potassium Salt

B3000-1G
EUR 327

Brite-Light? D-Luciferin, Potassium Salt

B3000-5PK
EUR 1300

D-Luciferin

B6040-10 10 mg
EUR 131
Description: D-luciferin is a cell-permeable chemiluminescent luciferase substrate with a Km of approximately 2 ?M. D-luciferin could emit lights upon oxidative decarboxylation in the presence of ATP.

D-Luciferin

B6040-200 200 mg
EUR 699
Description: D-luciferin is a cell-permeable chemiluminescent luciferase substrate with a Km of approximately 2 ?M. D-luciferin could emit lights upon oxidative decarboxylation in the presence of ATP.

D-Luciferin

B6040-50 50 mg
EUR 293
Description: D-luciferin is a cell-permeable chemiluminescent luciferase substrate with a Km of approximately 2 ?M. D-luciferin could emit lights upon oxidative decarboxylation in the presence of ATP.

D-Luciferin

HY-12591A 10mg
EUR 108

D-Luciferin

GP9319-100MG 100 mg
EUR 221

D-Luciferin

GP9319-10MG 10 mg
EUR 70

D-Luciferin

GP9319-25MG 25 mg
EUR 110

D-Luciferin

GP9319-50MG 50 mg
EUR 150

D-Luciferin, potassium salt *CAS#: 115144-35-9*

12505 25 mg
EUR 115
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 41105331

D-Luciferin, potassium salt *CAS#: 115144-35-9*

12506 100 mg
EUR 132
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 41105331

D-Luciferin, potassium salt *CAS#: 115144-35-9*

12507 1 g
EUR 263
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 41105331

D-Luciferin acetate

12516 5 mg
EUR 219
  • R-phrase: R20, R21, R22
  • H-Phrase: H303, H313, H333
  • Symbol for dangerous compounds: Xn
  • UNSPEC Code: 41105331

Estradiol 17-(?-D-Glucuronide) (sodium salt)

C3840-10 10 mg
EUR 206
Description: Km: 75 ?MEstradiol 17-(?-D-Glucuronide) is a substrate of the multidrug resistance protein 2 (MRP2).MRP2 is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes.

Estradiol 17-(?-D-Glucuronide) (sodium salt)

C3840-25 25 mg
EUR 338
Description: Km: 75 ?MEstradiol 17-(?-D-Glucuronide) is a substrate of the multidrug resistance protein 2 (MRP2).MRP2 is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes.

Estradiol 17-(?-D-Glucuronide) (sodium salt)

C3840-5 5 mg
EUR 132
Description: Km: 75 ?MEstradiol 17-(?-D-Glucuronide) is a substrate of the multidrug resistance protein 2 (MRP2).MRP2 is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes.

Estradiol 17-(?-D-Glucuronide) (sodium salt)

C3840-50 50 mg
EUR 502
Description: Km: 75 ?MEstradiol 17-(?-D-Glucuronide) is a substrate of the multidrug resistance protein 2 (MRP2).MRP2 is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes.

Estradiol 3-(?-D-Glucuronide) (sodium salt)

C3897-1 1 mg
EUR 118
Description: ?-estradiol 3-(?-d-glucuronide) (E23G) is a noncholestatic regioisomer of the estrogen metabolite, E217G (?-Estradiol 17-(?-d-glucuronide)) [1]. E23G functions as a substrate for multidrug resistance associated protein 2 (MRP2) [2].

Estradiol 3-(?-D-Glucuronide) (sodium salt)

C3897-10 10 mg
EUR 527
Description: ?-estradiol 3-(?-d-glucuronide) (E23G) is a noncholestatic regioisomer of the estrogen metabolite, E217G (?-Estradiol 17-(?-d-glucuronide)) [1]. E23G functions as a substrate for multidrug resistance associated protein 2 (MRP2) [2].

Estradiol 3-(?-D-Glucuronide) (sodium salt)

C3897-25 25 mg
EUR 1073
Description: ?-estradiol 3-(?-d-glucuronide) (E23G) is a noncholestatic regioisomer of the estrogen metabolite, E217G (?-Estradiol 17-(?-d-glucuronide)) [1]. E23G functions as a substrate for multidrug resistance associated protein 2 (MRP2) [2].

Estradiol 3-(?-D-Glucuronide) (sodium salt)

C3897-5 5 mg
EUR 306
Description: ?-estradiol 3-(?-d-glucuronide) (E23G) is a noncholestatic regioisomer of the estrogen metabolite, E217G (?-Estradiol 17-(?-d-glucuronide)) [1]. E23G functions as a substrate for multidrug resistance associated protein 2 (MRP2) [2].

Methyl beta-D-glucuronide sodium salt

GC4190-1G 1 g
EUR 229

Methyl beta-D-glucuronide sodium salt

GC4190-250MG 250 mg
EUR 110

D-Glucuronic acid sodium salt monohydrate

GC8431-100G 100 g
EUR 126

D-Glucuronic acid sodium salt monohydrate

GC8431-250G 250 g
EUR 229

D-Glucuronic acid sodium salt monohydrate

GC8431-25G 25 g
EUR 70

D-Glucuronic acid sodium salt monohydrate

GC8431-5G 5 g
EUR 46

D-Glucosamine 2-sulfate sodium salt

GC9126-25MG 25 mg
EUR 61

D-Glucuronic acid, sodium salt, monohydrate

GB0483 5g
EUR 107.42
  • Product category: Biochemicals/Carbohydrates/Sugars

D-Luciferin, free acid

10100 10MG
EUR 112
Description: Minimum order quantity: 1 unit of 10MG

D-Luciferin, free acid

10100-1 50MG
EUR 234
Description: Minimum order quantity: 1 unit of 50MG

D-Luciferin, free acid

10100-2 1G
EUR 714
Description: Minimum order quantity: 1 unit of 1G

D-Luciferin (Free acid)

2779-1000
EUR 338

D-Luciferin (Free acid)

2779-250
EUR 175

D-Luciferin (Free acid)

2779-500
EUR 251

D-Luciferin (Free acid)

2779-5000
EUR 1273

Ampicillin Sodium Salt

AK0839-0010 10g Ask for price

Ampicillin Sodium Salt

AK0839-0025 25g Ask for price

Ampicillin Sodium Salt

AK0839-0100 100g Ask for price

Heparin Sodium Salt

AK3004-1000 1g Ask for price

Heparin Sodium Salt

AK3004-5000 5g Ask for price

Cefonicid (sodium salt)

C3812-1000 1 g
EUR 406
Description: Cefonicid is a second-generation cephalosporin antibiotic.Cephalosporins, the largest and most diverse family of antibiotics of the beta-lactam group, are structurally and pharmacologically related to the penicillins.

Cefonicid (sodium salt)

C3812-5.1 10 mM (in 1mL DMSO)
EUR 113
Description: Cefonicid is a second-generation cephalosporin antibiotic.Cephalosporins, the largest and most diverse family of antibiotics of the beta-lactam group, are structurally and pharmacologically related to the penicillins.

Cefonicid (sodium salt)

C3812-500 500 mg
EUR 251
Description: Cefonicid is a second-generation cephalosporin antibiotic.Cephalosporins, the largest and most diverse family of antibiotics of the beta-lactam group, are structurally and pharmacologically related to the penicillins.

Cefoperazone (sodium salt)

C3913-10000 10 g
EUR 403
Description: Cefoperazone is a new semisynthetic cephalosporin with a broad spectrum of antibacterial activity. Cefoperazone shows high activity against gram-positive bacteria and gram-negative bacilli, such as Escherichia coli, Klebsiella pneumoniae, and Proteus species [1].

Cefoperazone (sodium salt)

C3913-5000 5 g
EUR 267
Description: Cefoperazone is a new semisynthetic cephalosporin with a broad spectrum of antibacterial activity. Cefoperazone shows high activity against gram-positive bacteria and gram-negative bacilli, such as Escherichia coli, Klebsiella pneumoniae, and Proteus species [1].

Moxalactam (sodium salt)

C4121-1000 1 g
EUR 225
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis.

Moxalactam (sodium salt)

C4121-250 250 mg
EUR 112
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis.

Moxalactam (sodium salt)

C4121-5.1 10 mM (in 1mL DMSO)
EUR 113
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis.

Moxalactam (sodium salt)

C4121-500 500 mg
EUR 168
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis.

Cefazolin (sodium salt)

C4183-1000 1 g
EUR 168
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1].

Cefazolin (sodium salt)

C4183-250 250 mg
EUR 105
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1].

Cefazolin (sodium salt)

C4183-5.1 10 mM (in 1mL DMSO)
EUR 113
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1].

Cefazolin (sodium salt)

C4183-500 500 mg
EUR 138
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1].

Tazobactam (sodium salt)

C4245-1000 1 g
EUR 226
Description: Tazobactam is a ?-lactamase inhibitor [1]. Tazobactam shows intrinsic activity against Acinetobacter strains. The ?-Lactamases are responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems.

Tazobactam (sodium salt)

C4245-250 250 mg
EUR 116
Description: Tazobactam is a ?-lactamase inhibitor [1]. Tazobactam shows intrinsic activity against Acinetobacter strains. The ?-Lactamases are responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems.

Tazobactam (sodium salt)

C4245-500 500 mg
EUR 168
Description: Tazobactam is a ?-lactamase inhibitor [1]. Tazobactam shows intrinsic activity against Acinetobacter strains. The ?-Lactamases are responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems.

Simvastatin (sodium salt)

C4426-100 100 mg
EUR 392
Description: Ki: 0.12 nMSimvastatin is a HMG-CoA reductase inhibitor. HMG-CoA reductase has been found to be the rate-limiting enzyme in the cholesterol biosynthetic pathway and the target of the ?statin? class of cholesterol-lowering drugs.

Simvastatin (sodium salt)

C4426-25 25 mg
EUR 196
Description: Ki: 0.12 nMSimvastatin is a HMG-CoA reductase inhibitor. HMG-CoA reductase has been found to be the rate-limiting enzyme in the cholesterol biosynthetic pathway and the target of the ?statin? class of cholesterol-lowering drugs.

Moniliformin (sodium salt)

C4459-1 1 mg
EUR 321
Description: Moniliformin induces mitotic arrest at the metaphase stage.Mitosis is a part of the cell cycle when replicated chromosomes are separated into two new nuclei.

Cefotaxime (sodium salt)

C4588-1000 1 g
EUR 126
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic.

Cefotaxime (sodium salt)

C4588-5.1 10 mM (in 1mL DMSO)
EUR 113
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic.

Cefotaxime (sodium salt)

C4588-500 500 mg
EUR 108
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic.

Cefotaxime (sodium salt)

C4588-5000 5 g
EUR 151
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic.

Lorglumide (sodium salt)

C4809-25 25 mg
EUR 145
Description: Lorglumide (sodium salt) is the first nonpeptidic, selective and potent inhibitor of the CCK-A receptor [1][2][3][4] .

Lorglumide (sodium salt)

C4809-50 50 mg
EUR 171
Description: Lorglumide (sodium salt) is the first nonpeptidic, selective and potent inhibitor of the CCK-A receptor [1][2][3][4] .

Cefoxitin (sodium salt)

C4849-1000 1 g
EUR 241
Description: Cefoxitin (sodium salt) is a second generation cephalosporin antibiotic that was used to treat a wide range of gram-negative and gram-positive bacteria [1][2].

Cefoxitin (sodium salt)

C4849-250 250 mg
EUR 113
Description: Cefoxitin (sodium salt) is a second generation cephalosporin antibiotic that was used to treat a wide range of gram-negative and gram-positive bacteria [1][2].

Cefoxitin (sodium salt)

C4849-500 500 mg
EUR 164
Description: Cefoxitin (sodium salt) is a second generation cephalosporin antibiotic that was used to treat a wide range of gram-negative and gram-positive bacteria [1][2].

Fosmidomycin (sodium salt)

C4898-10 10 mg
EUR 415
Description: Fosmidomycin is a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXP) [1]. Fosmidomycin is an antibiotic originally isolated from bacteria of the genus Streptomyces.

Fosmidomycin (sodium salt)

C4898-25 25 mg
EUR 830
Description: Fosmidomycin is a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXP) [1]. Fosmidomycin is an antibiotic originally isolated from bacteria of the genus Streptomyces.

Fosmidomycin (sodium salt)

C4898-5 5 mg
EUR 244
Description: Fosmidomycin is a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXP) [1]. Fosmidomycin is an antibiotic originally isolated from bacteria of the genus Streptomyces.

Cefsulodin (sodium salt)

C5593-1000 1 g
EUR 224
Description: Cefsulodin, formerly named as SCE-129, is a cephalosporin with a spectrum of antibacterial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and most other gram-positive cocci [1].

Cefsulodin (sodium salt)

C5593-250 250 mg
EUR 123
Description: Cefsulodin, formerly named as SCE-129, is a cephalosporin with a spectrum of antibacterial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and most other gram-positive cocci [1].

Cefsulodin (sodium salt)

C5593-500 500 mg
EUR 180
Description: Cefsulodin, formerly named as SCE-129, is a cephalosporin with a spectrum of antibacterial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and most other gram-positive cocci [1].

Furegrelate (sodium salt)

C5692-10 10 mg
EUR 170
Description: Furegrelate (sodium salt) is a potent inhibitor of thromboxane synthase [1][2].Thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) is a cytochrome P450 enzyme that catalyzes the conversion of prostaglandin H2 to thromboxane A2.

Furegrelate (sodium salt)

C5692-5 5 mg
EUR 112
Description: Furegrelate (sodium salt) is a potent inhibitor of thromboxane synthase [1][2].Thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) is a cytochrome P450 enzyme that catalyzes the conversion of prostaglandin H2 to thromboxane A2.

Furegrelate (sodium salt)

C5692-50 50 mg
EUR 551
Description: Furegrelate (sodium salt) is a potent inhibitor of thromboxane synthase [1][2].Thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) is a cytochrome P450 enzyme that catalyzes the conversion of prostaglandin H2 to thromboxane A2.

Cefoxitin Sodium Salt

B1892-1G
EUR 185

Cefoxitin Sodium Salt

B1892-500
EUR 131

Cefoxitin Sodium Salt

B1892-5G
EUR 577

Azlocillin sodium salt

B1893-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Azlocillin is an acylampicillin with a broad spectrum against bacteria.

Azlocillin sodium salt

B1893-50 50 mg
EUR 128
Description: Azlocillin is an acylampicillin with a broad spectrum against bacteria.

Azlocillin sodium salt

B1893-S Evaluation Sample
EUR 81
Description: Azlocillin is an acylampicillin with a broad spectrum against bacteria.

Sulfamerazine sodium salt

B3430-100000 100 g
EUR 137
Description: Sulfamerazine Sodium is a sulfonamide antibacterial.

Sulfamerazine sodium salt

B3430-50000 50 g
EUR 110
Description: Sulfamerazine Sodium is a sulfonamide antibacterial.

GSK1349572 sodiuM salt

B5856-10 10 mg
EUR 316
Description: Integrase inhibitors are a new class of antiretroviral drugs blocking the action of HIV integrase, which catalyses several key steps in the life cycle of the virus and is essential for insertion of the viral genome into the host cell DNA. GSK1349572 is a next-generation HIV integrase (IN) inhibitor.

GSK1349572 sodiuM salt

B5856-100 100 mg
EUR 1210
Description: Integrase inhibitors are a new class of antiretroviral drugs blocking the action of HIV integrase, which catalyses several key steps in the life cycle of the virus and is essential for insertion of the viral genome into the host cell DNA. GSK1349572 is a next-generation HIV integrase (IN) inhibitor.

GSK1349572 sodiuM salt

B5856-5 5 mg
EUR 241
Description: Integrase inhibitors are a new class of antiretroviral drugs blocking the action of HIV integrase, which catalyses several key steps in the life cycle of the virus and is essential for insertion of the viral genome into the host cell DNA. GSK1349572 is a next-generation HIV integrase (IN) inhibitor.

GSK1349572 sodiuM salt

B5856-50 50 mg
EUR 728
Description: Integrase inhibitors are a new class of antiretroviral drugs blocking the action of HIV integrase, which catalyses several key steps in the life cycle of the virus and is essential for insertion of the viral genome into the host cell DNA. GSK1349572 is a next-generation HIV integrase (IN) inhibitor.

Resazurin sodium salt

B6098-1000 1 g
EUR 84
Description: The non-fluorescent resazurin has been used as a fluorogenic oxidation-reduction indicator in various cells by flow cytometry, fluorescence microscopy and high-throughput screening. Its red-fluorescent product, resorufin, has absorption/emission maxima ~575/585 nm.

Resazurin sodium salt

B6098-5000 5 g
EUR 166
Description: The non-fluorescent resazurin has been used as a fluorogenic oxidation-reduction indicator in various cells by flow cytometry, fluorescence microscopy and high-throughput screening. Its red-fluorescent product, resorufin, has absorption/emission maxima ~575/585 nm.

Dantrolene, sodium salt

B6329-100 100 mg
EUR 132

Dantrolene, sodium salt

B6329-5.1 10 mM (in 1mL DMSO)
EUR 108

Entacapone sodium salt

B1090-10 10 mg
EUR 139
Description: Entacapone, a nitrocatechol compound, is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT), a Mg2+-dependent enzyme involved in the metabolism of catecholamines and catechol compounds.

Entacapone sodium salt

B1090-100 100 mg
EUR 321
Description: Entacapone, a nitrocatechol compound, is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT), a Mg2+-dependent enzyme involved in the metabolism of catecholamines and catechol compounds.

Entacapone sodium salt

B1090-50 50 mg
EUR 231
Description: Entacapone, a nitrocatechol compound, is a selective and reversible inhibitor of catechol-O-methyltransferase (COMT), a Mg2+-dependent enzyme involved in the metabolism of catecholamines and catechol compounds.

Adapalene sodium salt

B1277-100 100 mg
EUR 142
Description: Adapalene sodium salt, a synthetic retinoid, is a Retinoic acid receptor agonist (RAR).

Adapalene sodium salt

B1277-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Adapalene sodium salt, a synthetic retinoid, is a Retinoic acid receptor agonist (RAR).

Adapalene sodium salt

B1277-50 50 mg
EUR 108
Description: Adapalene sodium salt, a synthetic retinoid, is a Retinoic acid receptor agonist (RAR).

Novobiocin Sodium Salt

B1526-1G
EUR 109

Novobiocin Sodium Salt

B1526-5G
EUR 240

Cefazolin Sodium Salt

B1530-1G
EUR 142

Cefazolin Sodium Salt

B1530-5G
EUR 359

GSK2190915 sodium salt

B4905-10 10 mg
EUR 429

GSK2190915 sodium salt

B4905-5 5 mg
EUR 277

GSK2190915 sodium salt

B4905-5.1 10 mM (in 1mL DMSO)
EUR 380

GSK2190915 sodium salt

B4905-50 50 mg
EUR 1549

Ischemin sodium salt

B4917-10 10 mg
EUR 268

Ischemin sodium salt

B4917-50 50 mg
EUR 973

Proglumide sodium salt

B5121-100 100 mg
EUR 139

Proglumide sodium salt

B5121-5.1 10 mM (in 1mL DMSO)
EUR 150

(±)-Cloprostenol sodium salt

B7004-1 1 mg
EUR 112

(±)-Cloprostenol sodium salt

B7004-10 10 mg
EUR 363

(±)-Cloprostenol sodium salt

B7004-5 5 mg
EUR 300

HEPES Sodium salt

B7303-250000 250 g
EUR 286

CHPG Sodium salt

B7475-10 10 mg
EUR 253

CHPG Sodium salt

B7475-50 50 mg
EUR 902

Nigericin sodium salt

B7644-10 10 mg
EUR 131
Description: Nigericin sodium salt is an ionophore that exchanges K+ for H+ across biological membranes.Ionophore is a lipid-soluble molecule that transports ions across the cell membrane.

Nigericin sodium salt

B7644-25 25 mg
EUR 212
Description: Nigericin sodium salt is an ionophore that exchanges K+ for H+ across biological membranes.Ionophore is a lipid-soluble molecule that transports ions across the cell membrane.

Nigericin sodium salt

B7644-5 5 mg
EUR 102
Description: Nigericin sodium salt is an ionophore that exchanges K+ for H+ across biological membranes.Ionophore is a lipid-soluble molecule that transports ions across the cell membrane.
Scroll to Top